A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner? (Q30497087)

17 October 2017

1 reference

8 February 2021

1 reference

PubMed publication ID

20932288

title

A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner? (English)

1 reference

positron emission tomography

17 October 2017

1 reference

27 October 2020

1 reference

14 November 2020

1 reference

23 November 2020

1 reference

8 February 2021

1 reference

ORCID Public Data File 2021

author name string

Astrid Langer

series ordinal

1

1 reference

17 October 2017

language of work or name

1 reference

8 October 2010

8 references

BMC Health Services Research

17 October 2017

3 April 2019

19 June 2019

25 June 2019

27 October 2020

14 November 2020

23 November 2020

8 February 2021

8 references

17 October 2017

3 April 2019

19 June 2019

25 June 2019

27 October 2020

14 November 2020

23 November 2020

8 February 2021

10

1 reference

17 October 2017

283

1 reference

Creative Commons Attribution 2.0 Generic

17 October 2017

7 references

3 April 2019

19 June 2019

25 June 2019

27 October 2020

14 November 2020

23 November 2020

on focus list of Wikimedia project

8 February 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The timing of adoption of positron emission tomography: a real options approach

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Integrated PET/CT in imaging of non-small cell lung cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

[Impact of FDG-PET on radiation therapy: economic results of a STIC study].

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Systematic reviews of economic evaluations: utility or futility?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Established, emerging and future roles of PET/CT in the management of colorectal cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The value of positron emission tomography in patients with non-small cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

PET imaging in the management of tumors of testis and ovary: current thinking and future directions.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Transferability indices for health economic evaluations: methods and applications.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Transferability of economic evaluations of medical technologies: a new technology for orthopedic surgery.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The roles of PET and PET/CT in the diagnosis and management of prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Mobile PET in the UK: legislative, regulatory and cost-effectiveness considerations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Who wants cancer screening with PET? A contingent valuation survey in Japan.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Imaging in staging of malignant lymphoma: a systematic review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Activity-based costing evaluation of [18F]-fludeoxyglucose production

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Ensuring the right PET scan for the right patient.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Is 18F FDG PET-CT cost effective in lung cancer?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

PET/CT in non-small cell lung cancer staging-promises and problems.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The role of positron emission tomography in the management of recurrent colorectal cancer: a review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

FDG-PET in colorectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Comparative accuracy: assessing new tests against existing diagnostic pathways

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

PET evaluation of lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Positron-emission tomography and assessment of cancer therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Integrated PET/CT: current applications and future directions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Can economic evaluations be made more transferable?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Decision analysis for the cost-effective management of recurrent colorectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

How to perform a comprehensive search for FDG-PET literature.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Analytical decision model for the cost-effective management of solitary pulmonary nodules

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

The cost of treating small cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

A Positron-Emission Transaxial Tomograph for Nuclear Imaging (PETT)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Recommendations on the use of 18F-FDG PET in oncology

20 June 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effectiveness of positron emission tomography in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

A decision chart for assessing and improving the transferability of economic evaluation results between countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

[Evaluation of PET-CT : product safety, clinical usefulness, reimbursement in Germany and the USA].

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Marginal cost of operating a positron emission tomography center in a regulatory environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Methodology for calculating a country's need for positron emission tomography scanners

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Activity-based costing evaluation of a [(18)F]-fludeoxyglucose positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Non-Hodgkin lymphoma: retrospective study on the cost-effectiveness of early treatment response assessment by FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

[Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

FDG PET scan strategies and long-term outcomes after first-line therapy in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

The measurement of willingness to pay for mass cancer screening with whole-body PET (positron emission tomography).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6963-10-283

Staging non-small lung cancer with positron emission tomography: diagnostic value, impact on patient management, and cost-effectiveness.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Cost effectiveness of positron emission tomography in Canada.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Cost-effectiveness of positron emission tomography for non-small cell lung carcinoma in Canada.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959014

Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan

26 November 2018

1 reference

12 December 2020

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

12 December 2020

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results

1 reference

12 December 2020

Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer

1 reference

12 December 2020

The implementation of PET in non-small-cell lung cancer in the Netherlands

1 reference

12 December 2020

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness

1 reference

12 December 2020

Is a methodology available that accurately measures the cost of an FDG-PET study?

1 reference

12 December 2020

Rising costs of medical imaging spur debate

1 reference

12 December 2020

An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography

1 reference

12 December 2020

Cost-effectiveness of medical imaging

1 reference

12 December 2020

Evaluation of Cost-effectiveness of FDG-PET in Non-Small Cell Lung Cancer.

1 reference

12 December 2020

Cost Effectiveness of Positron Emission Tomography for Characterizing Pulmonary Nodules

1 reference

12 December 2020

Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-10-283

1 reference

Dimensions Publication ID

17 October 2017

0 references

1 reference

17 October 2017

PubMed publication ID

20932288

1 reference